BCAB
BioAtla, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.74
+31.44%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$7.00
- Revenue estimate
- $5.6M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- $0.27
- EPS estimate
- -$8.50
- Revenue actual
- $6.5M
- Revenue estimate
- $6.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +51.8%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$8.50 | $0.27 | Beat 103.18% | $6.5M |
| May 15, 2026 | -$10 | -$4.22 | Beat 57.80% | — |
| Mar 31, 2026 | -$0.24 | -$0.16 | Beat 33.33% | $2.0M |
| Nov 13, 2025 | -$0.31 | -$0.27 | Beat 12.90% | — |
| Aug 7, 2025 | -$0.29 | -$0.31 | Miss -6.90% | — |
| Mar 27, 2025 | -$0.40 | -$0.32 | Beat 20.00% | — |
| Nov 7, 2024 | -$0.34 | -$0.22 | Beat 35.29% | $11.0M |
| Aug 8, 2024 | -$0.45 | -$0.44 | Beat 2.22% | — |
| May 11, 2023 | -$0.66 | -$0.58 | Beat 12.12% | — |
| Mar 23, 2023 | -$0.74 | -$0.63 | Beat 14.86% | — |
| Nov 4, 2022 | -$0.77 | -$0.69 | Beat 10.39% | — |
| May 5, 2022 | -$0.69 | -$0.65 | Beat 5.80% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026